Mckesson (MCK) Shares Outstanding (Diluted Average) (2009 - 2026)
Mckesson (MCK) reported Shares Outstanding (Diluted Average) of $124.1 million for Q1 2026, down 3.12% year-over-year from $128.1 million in Q1 2025, and little changed quarter-over-quarter from $123.7 million in Q4 2025.
Mckesson (MCK) Shares Outstanding (Diluted Average) (2009 - 2026) Analysis & Trends
Mckesson (MCK) has 15 years of Shares Outstanding (Diluted Average) data on file, last reported at $124.1 million in Q1 2026.
- Shares Outstanding (Diluted Average) for Q1 2026 came in at $124.1 million, down 3.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $124.1 million (down 3.12% YoY), and the FY2026 annual result was $124.1 million, down 3.12% from the prior year.
- Shares Outstanding (Diluted Average) was little changed at $124.1 million in Q1 2026 per MCK's latest filing, from $123.7 million in the prior quarter.
- Over five years, Shares Outstanding (Diluted Average) peaked at $154.1 million in Q1 2022 and troughed at $123.7 million in Q4 2025.
- A 5-year average of $133.1 million and a median of $130.7 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
- The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Diluted Average) retreated 7.72% in 2022, then declined 2.29% in 2025.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $144.1 million in 2022, then fell by 7.49% to $133.3 million in 2023, then retreated by 5.03% to $126.6 million in 2024, then retreated by 2.29% to $123.7 million in 2025, then grew by 0.32% to $124.1 million in 2026.
- Business Quant data shows MCK's Shares Outstanding (Diluted Average) at $124.1 million in Q1 2026, $123.7 million in Q4 2025, and $124.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | 1.00 |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 124.10 Mn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 195.38 Mn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 236.00 Mn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 116.06 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | - |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 37.48 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 24.54 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 47.09 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | 14.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 124.10 Mn |
| Dec 31, 2025 | 123.70 Mn |
| Sep 30, 2025 | 124.90 Mn |
| Jun 30, 2025 | 125.50 Mn |
| Mar 31, 2025 | 128.10 Mn |
| Dec 31, 2024 | 126.60 Mn |
| Sep 30, 2024 | 129.30 Mn |
| Jun 30, 2024 | 130.70 Mn |
| Mar 31, 2024 | 134.10 Mn |
| Dec 31, 2023 | 133.30 Mn |
| Sep 30, 2023 | 134.80 Mn |
| Jun 30, 2023 | 136.60 Mn |
| Sep 30, 2022 | 144.10 Mn |
| Jun 30, 2022 | 145.90 Mn |
| Mar 31, 2022 | 154.10 Mn |
| Jun 30, 2021 | 158.10 Mn |
| Mar 31, 2021 | 160.60 Mn |
| Mar 31, 2020 | 181.60 Mn |
| Sep 30, 2016 | 228.00 Mn |
| Jun 30, 2016 | 228.00 Mn |